Therapy Area topics

Cardiovascular

Diabetes

Digital Health

Oncology

Vantage logo

Abbvie takes its Treg cue

The big pharma becomes the latest to look at IL-2 to harness regulatory T cells, but plenty of others have the same idea.

Respiratory

Various

Vantage logo
Independent, data-driven daily news and analysis on pharma, biotech and medtech.